Vascular Stents Market Research Report - Global Forecast till 2027

Global Vascular Stents Market Research Report: Information by Type [Coronary Stents, Peripheral Stents (Carotid Artery Stents, Renal Artery Stents, Femoral Artery Stents, Iliac Artery Stents and others) and Evar Stent Grafts (Abdominal Aortic Aneurysm Stents and Thoracic Aortic Aneurysm Stents)], Material [Metallic Stents (Platinum Chromium, Cobalt-Chromium, Nickel-Titanium and Stainless Steel), Ceramics Stents and Polymers Stents], End User (Hospitals, Cardiac Centers, and Ambulatory Surgical Centers) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2027

ID: MRFR/MED/0899-HCR | February 2021 | Region: Global | 95 pages

Please note that the assessment period of report has been updated from 2019-2025 to 2020-2027. Cordially fill Sample form for the updated data.

Market Scenario


Vascular Stents Market is expected to register 7.7% CAGR during the forecast period of 2019 to 2025, with a market value of USD 16788.9 Million in 2018.


Vascular stents are rigid devices used to provide support for hollow, usually tubular, structures that are being held in one position.


The global vascular stents market is driven by factors such as the increasing incidences of vascular diseases and innovations in stenting technologies.


Additionally, increasing preference for minimally invasive surgeries coupled with rapid growth in the geriatric population is anticipated to fuel the market growth.


For instance, according to the World Health Organization (WHO), cardiovascular diseases (CVDs) are the leading cause of death globally. An estimated 17.9 million people died from CVDs in 2016. It also represents 31% of all global deaths and 85% of the deaths are due to heart attack and stroke.


On the other hand, product recalls and failures are projected to hamper the growth of the market during the assessment period.


Moreover, major companies in the market are involved in strategic acquisitions, collaborations, mergers, and product launches to sustain their position in the competitive global market.


For instance, in February 2018, Medtronic launched a 2.0-mm drug-eluting stent for the market in the US.


Segmentation


The Global Vascular Stents Market has been segmented based on type, material, end user, and region.


The global market, based on type, has been bifurcated into coronary stents, peripheral stents, and evar stent grafts. The peripheral stents are further subdivided into carotid artery stents, renal artery stents, femoral artery stents, iliac artery stents, and others. Similarly, the evar stent grafts segment is further sub-segmented into abdominal aortic aneurysm stents and thoracic aortic aneurysm stents.


The coronary stents are expected to hold a major share in the market due to the increasing incidences of coronary artery diseases and technological improvement in coronary stents. For example, American College of Cardiology estimated that approximately every 40 seconds, an American would have a myocardial infarction (MI). Based on material, the global market is segmented into metallic stents, ceramics stents, and polymers stents. The metallic stents segment is further classified into platinum chromium, cobalt chromium, nickel titanium, and stainless steel. The polymers stents are expected to hold a major share in the market due growing use of bioabsorbable stents and technological improvement in coronary stents.


Based on end user, the global market is segmented into hospitals, cardiac centers, and ambulatory surgical centers. The hospitals segment is expected to hold a major share of the market due to the availability of facilities for angioplasty procedures and expertise in the hospital.


The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The vascular stents market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European vascular stents market has been sub-divided into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.


The vascular stents market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The vascular stents market in the Middle East & Africa has been divided into the Middle East and Africa.


Key Players


The Key Players operating in the Global Vascular Stents Market are Abbott Laboratories (US), B. Braun Melsungen Ag (Germany), Medtronic Plc (Ireland), Boston Scientific Corporation (US), Terumo Corporation (Japan), Biotronik Se & Co. Kg (Germany), Microport Scientific Corporation (China), Cook Medical  (US), Vascular Concepts (India), Stentys S.A. (France), C. R. Bard (US), Meril Life Sciences (India), Cordis Corporation (US), and W. L. Gore & Associates (US).


Regional Market Summary


Global Vascular Stents Market Share, by Region, 2018 (%)  Vascular Stents Market


Source: World Health Organization (WHO)


The market in the Americas is expected to dominate the global vascular stents market due to the increasing prevalence of vascular diseases and the high adoption of new technology in the region. Growing preferences for minimally invasive procedures in the US and Canada is expected to drive the market growth. Furthermore, increasing investments in healthcare research is expected to fuel the growth of the market in this region. For example, according to in 2019, American College of Cardiology in the US, coronary events are expected to occur in about 1,055,000 individuals, which include 720,000 new and 335,000 recurrent coronary events. The market in Europe expected to show a considerable amount of growth. This can be attributed to the presence of a well-established healthcare system, innovations in stenting technologies and the involvement of key companies. The market in Asia-Pacific is projected to have a steady growth rate during the forecast period owing to an increasing prevalence of vascular disease and rapid growth in the geriatric population. For example, according to the Economic and Social Commission for Asia and the Pacific (ESCAP) in 2016, approximately 12.4 percent of the population in the region was 60 years or older, but this is projected to increase to more than a quarter or 1.3 billion people by 2050. The market in the Middle East & Africa is projected to account for the least share of the market due to the low per capita disposable income in the region.


Global Vascular Stents Market, by Type



  • Coronary Stents

  • Peripheral Stents

  • Evar Stent Grafts


Global Vascular Stents Market, By Material



  • Metallic Stents

  • Platinum Chromium

  • Cobalt Chromium

  • Nickel Titanium

  • Stainless Steel

  • Ceramics Stents

  • Polymers Stents


Global Vascular Stents Market, by End User



  • Hospitals

  • Cardiac Centers

  • Ambulatory Surgical Centers


Global Vascular Stents Market, by Region



  • Americas

    • North America

      • US

      • Canada



    • Latin America





  • Europe

    • Western Europe

      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe



    • Eastern Europe





  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific





  • Middle East & Africa

    • Middle East

    • Africa




Intended Audience



  • Research and development (R&D) companies

  • Pharmaceutical & biotechnology companies

  • Government research institutes

  • Academic institutes and universities

  • Venture capitalists



Report Scope:
Report Attribute/Metric Details
  Market Size   USD 16788.9 Million (2018)
  CAGR   7.7% (2019-2025)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Information by Type, Evar Stent Grafts, Material
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Abbott Laboratories (US), B. Braun Melsungen Ag (Germany), Medtronic Plc (Ireland), Boston Scientific Corporation (US), Terumo Corporation (Japan), Biotronik Se & Co. Kg (Germany), Microport Scientific Corporation (China), Cook Medical (US), Vascular Concepts (India), Stentys S.A. (France), C. R. Bard (US), Meril Life Sciences (India), Cordis Corporation (US), and W. L. Gore & Associates (US).
  Key Market Opportunities   Increasing preference for minimally invasive surgeries coupled with rapid growth in the geriatric population is anticipated to fuel the market growth.
  Key Market Drivers   Product recalls and failures are projected to hamper the growth of the market during the assessment period.


Frequently Asked Questions (FAQ) :


The valuation of the global vascular stents market had reached USD 16788.9 MN in 2018.

The global vascular stents market is projected to grow at 7.7% CAGR during the assessment period (2019-2025).

Growing prevalence of vascular diseases and technological advances in the stents are the major tailwinds pushing the growth of the global vascular stents market.

North America holds the largest share in the global vascular stents market, followed by Europe and the Asia Pacific, respectively.

Abbott Laboratories (US), Boston Scientific Corporation (US), Medtronic, Plc (UK), Biotronik se & co. kg (Germany), Cook Medical (US), B. Braun Melsungen AG (Germany), Lombard Medical Technologies (UK), Cordis (US), Translumina GmbH (Germany), Terumo Corporation (Japan), MicroPort Scientific Corporation (China), Vascular Concepts (India), Meril Life Sciences Pvt. Ltd. (India), and W.L. Gore & Associates (US), are some of the major players operating in the vascular stents market.

Table of Contents

1. REPORT PROLOGUE

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Primary Research

3.3. Secondary Research

3.4. Market Size Estimation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis


6. GLOBAL VASCULAR STENTS MARKET, BY TYPE

6.1. Overview

6.2. Coronary Stents

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.1. Carotid Artery Stents

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.2. Renal Artery Stents

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.3. Femoral Artery Stents

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.4. Iliac Artery Stents

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.5. Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3. Peripheral Stents

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.4. Evar Stent Grafts

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.4.1. Abdominal Aortic Aneurysm Stents

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.4.2. Thoracic Aortic Aneurysm Stents

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7. GLOBAL VASCULAR STENTS MARKET, BY MATERIAL

7.1. Overview

7.2. Metallic Stents

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.2.1. Platinum Chromium

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.2.2. Cobalt-Chromium

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.2.3. Nickel Titanium

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.2.4. Stainless Steel

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3. Ceramics Stents

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4. Polymers Stents

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8. GLOBAL VASCULAR STENTS MARKET, BY END USER

8.1. Overview

8.2. Hospitals

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3. Cardiac Centers

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4. Ambulatory Surgical Centers

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9. GLOBAL VASCULAR STENTS MARKET, BY REGION

9.1. Overview

9.2. Americas

9.2.1. North America

9.2.1.1. US

9.2.1.2. Canada

9.2.2. Latin America

9.3. Europe

9.3.1. Western Europe

9.3.1.1. Germany

9.3.1.2. France

9.3.1.3. Italy

9.3.1.4. Spain

9.3.1.5. UK

9.3.1.6. Rest of Western Europe

9.3.2. Eastern Europe

9.4. Asia-Pacific

9.4.1. Japan

9.4.2. China

9.4.3. India

9.4.4. Australia

9.4.5. South Korea

9.4.6. Rest of Asia-Pacific

9.5. Middle East & Africa

9.5.1. Middle East

9.5.2. Africa

10. COMPANY LANDSCAPE

10.1. Overview

10.2. Competitive Analysis

10.3. Market Share Analysis

10.4. Major Growth Strategy in the Global Vascular Stents Market

10.5. Competitive Benchmarking

10.6. Leading Players in Terms of Number of Developments in the Global Vascular Stents Market

10.7. Key developments and Growth Strategies

10.7.1. Product Launch/Service Deployment

10.7.2. Mergers and Acquisitions

10.7.3. Joint Ventures

10.8. Major Players Financial Matrix & Market Ratio

10.8.1. Sales & Operating Income 2020

10.8.2. Major Players R&D Expenditure 2020

10.9. Major Players Capital Market Ratio

11. COMPANY PROFILES

11.1. Abbott Laboratories

11.1.1. Company Overview

11.1.2. Product Overview

11.1.3. Financial Overview

11.1.4. Key Developments

11.1.5. SWOT Analysis

11.1.6. Key Strategies

11.2. B. Braun Melsungen Ag

11.2.1. Company Overview

11.2.2. Product Overview

11.2.3. Financial Overview

11.2.4. Key Developments

11.2.5. SWOT Analysis

11.2.6. Key Strategies

11.3. Medtronic Plc

11.3.1. Company Overview

11.3.2. Product Overview

11.3.3. Financial Overview

11.3.4. Key Developments

11.3.5. SWOT Analysis

11.3.6. Key Strategies

11.4. Boston Scientific Corporation

11.4.1. Company Overview

11.4.2. Product Overview

11.4.3. Financial Overview

11.4.4. Key Developments

11.4.5. SWOT Analysis

11.4.6. Key Strategies

11.5. Terumo Corporation

11.5.1. Company Overview

11.5.2. Product Overview

11.5.3. Financial Overview

11.5.4. Key Developments

11.5.5. SWOT Analysis

11.5.6. Key Strategies

11.6. Biotronik Se & Co. Kg

11.6.1. Company Overview

11.6.2. Product Overview

11.6.3. Financial Overview

11.6.4. Key Developments

11.6.5. SWOT Analysis

11.6.6. Key Strategies

11.7. Microport Scientifc Corporation

11.7.1. Company Overview

11.7.2. Product Overview

11.7.3. Financial Overview

11.7.4. Key Developments

11.7.5. SWOT Analysis

11.7.6. Key Strategies

11.8. Cook Medical

11.8.1. Company Overview

11.8.2. Product Overview

11.8.3. Financial Overview

11.8.4. Key Developments

11.8.5. SWOT Analysis

11.8.6. Key Strategies

11.9. Vascular Concepts

11.9.1. Company Overview

11.9.2. Product Overview

11.9.3. Financial Overview

11.9.4. Key Developments

11.9.5. SWOT Analysis

11.9.6. Key Strategies

11.10. Stentys S.A.

11.10.1. Company Overview

11.10.2. Product Overview

11.10.3. Financial Overview

11.10.4. Key Developments

11.10.5. SWOT Analysis

11.10.6. Key Strategies

11.11. C. R. Bard

11.12. Meril Life Sciences

11.13. Cordis Corporation

11.14. W. L. Gore & Associates

11.15. Others

12. APPENDIX

12.1. References

12.2. Related Reports


LIST OF TABLES

TABLE 1 GLOBAL VASCULAR STENTS MARKET SYNOPSIS, 2020-2027

TABLE 2 GLOBAL VASCULAR STENTS MARKET ESTIMATES & FORECAST, 2020-2027 (USD MILLION)

TABLE 3 GLOBAL VASCULAR STENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 4 GLOBAL VASCULAR STENTS MARKET, BY MATERIAL, 2020-2027 (USD MILLION)

TABLE 5 GLOBAL VASCULAR STENTS MARKET, BY END USE, 2020-2027 (USD MILLION)

TABLE 6 GLOBAL VASCULAR STENTS MARKET, BY REGION, 2020-2027 (USD MILLION)

TABLE 7 NORTH AMERICA: VASCULAR STENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 8 NORTH AMERICA: VASCULAR STENTS MARKET, BY MATERIAL, 2020-2027 (USD MILLION)

TABLE 9 NORTH AMERICA: VASCULAR STENTS MARKET, BY END USE, 2020-2027 (USD MILLION)

TABLE 10 US: VASCULAR STENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 11 US: VASCULAR STENTS MARKET, BY MATERIAL, 2020-2027 (USD MILLION)

TABLE 12 US: VASCULAR STENTS MARKET, BY END USE, 2020-2027 (USD MILLION)

TABLE 13 CANADA: VASCULAR STENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 14 CANADA: VASCULAR STENTS MARKET, BY MATERIAL, 2020-2027 (USD MILLION)

TABLE 15 CANADA: VASCULAR STENTS MARKET, BY END USE, 2020-2027 (USD MILLION)

TABLE 16 LATIN AMERICA: VASCULAR STENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 17 LATIN AMERICA: VASCULAR STENTS MARKET, BY MATERIAL, 2020-2027 (USD MILLION)

TABLE 18 LATIN AMERICA: VASCULAR STENTS MARKET, BY END USE, 2020-2027 (USD MILLION)

TABLE 19 EUROPE: VASCULAR STENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 20 EUROPE: VASCULAR STENTS MARKET, BY MATERIAL, 2020-2027 (USD MILLION)

TABLE 21 EUROPE: VASCULAR STENTS MARKET, BY END USE, 2020-2027 (USD MILLION)

TABLE 22 WESTERN EUROPE: VASCULAR STENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 23 WESTERN EUROPE: VASCULAR STENTS MARKET, BY MATERIAL, 2020-2027 (USD MILLION)

TABLE 24 WESTERN EUROPE: VASCULAR STENTS MARKET, BY END USE, 2020-2027 (USD MILLION)

TABLE 25 EASTERN EUROPE: VASCULAR STENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 26 EASTERN EUROPE: VASCULAR STENTS MARKET, BY MATERIAL, 2020-2027 (USD MILLION)

TABLE 27 EASTERN EUROPE: VASCULAR STENTS MARKET, BY END USE, 2020-2027 (USD MILLION)

TABLE 28 ASIA-PACIFIC: VASCULAR STENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 29 ASIA-PACIFIC: VASCULAR STENTS MARKET, BY MATERIAL, 2020-2027 (USD MILLION)

TABLE 30 ASIA-PACIFIC: VASCULAR STENTS MARKET, BY END USE, 2020-2027 (USD MILLION)

TABLE 31 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 32 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY MATERIAL, 2020-2027 (USD MILLION)

TABLE 33 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY END USE, 2020-2027 (USD MILLION)


LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE OF THE GLOBAL VASCULAR STENTS MARKET

FIGURE 3 MARKET DYNAMICS OF THE GLOBAL VASCULAR STENTS MARKET

FIGURE 4 GLOBAL VASCULAR STENTS MARKET SHARE, BY TYPE, 2020 (%)

FIGURE 5 GLOBAL VASCULAR STENTS MARKET SHARE, BY MATERIAL, 2020 (%)

FIGURE 6 GLOBAL VASCULAR STENTS MARKET SHARE, BY END USE, 2020 (%)

FIGURE 7 GLOBAL VASCULAR STENTS MARKET SHARE, BY REGION, 2020 (%)

FIGURE 8 AMERICAS: VASCULAR STENTS MARKET SHARE BY REGION, 2020 (%)

FIGURE 9 NORTH AMERICA: VASCULAR STENTS MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 10 EUROPE: VASCULAR STENTS MARKET SHARE, BY REGION, 2020 (%)

FIGURE 11 WESTERN EUROPE: VASCULAR STENTS MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 12 ASIA-PACIFIC: VASCULAR STENTS MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 13 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 14 GLOBAL VASCULAR STENTS MARKET: COMPANY SHARE ANALYSIS, 2020 (%)

FIGURE 15 ABBOTT LABORATORIES.: KEY FINANCIALS

FIGURE 16 ABBOTT LABORATORIES: SEGMENTAL REVENUE

FIGURE 17 ABBOTT LABORATORIES: REGIONAL REVENUE

FIGURE 18 B. BRAUN MELSUNGEN AG: KEY FINANCIALS

FIGURE 19 B. BRAUN MELSUNGEN AG: SEGMENTAL REVENUE

FIGURE 20 B. BRAUN MELSUNGEN AG: REGIONAL REVENUE

FIGURE 21 MEDTRONIC PLC: KEY FINANCIALS

FIGURE 22 MEDTRONIC PLC: SEGMENTAL REVENUE

FIGURE 23 MEDTRONIC PLC: REGIONAL REVENUE

FIGURE 24 BOSTON SCIENTIFIC CORPORATION: KEY FINANCIALS

FIGURE 25 BOSTON SCIENTIFIC CORPORATION: SEGMENTAL REVENUE

FIGURE 26 BOSTON SCIENTIFIC CORPORATION: REGIONAL REVENUE

FIGURE 27 TERUMO CORPORATION: KEY FINANCIALS

FIGURE 28 TERUMO CORPORATION: SEGMENTAL REVENUE

FIGURE 29 TERUMO CORPORATION: REGIONAL REVENUE

FIGURE 30 BIOTRONIK SE & CO. KG: KEY FINANCIALS

FIGURE 31 BIOTRONIK SE & CO. KG: SEGMENTAL REVENUE

FIGURE 32 BIOTRONIK SE & CO. KG: REGIONAL REVENUE

FIGURE 33 MICROPORT SCIENTIFC CORPORATION: KEY FINANCIALS

FIGURE 34 MICROPORT SCIENTIFC CORPORATION: SEGMENTAL REVENUE

FIGURE 35 MICROPORT SCIENTIFC CORPORATION: REGIONAL REVENUE

FIGURE 36 COOK MEDICAL: KEY FINANCIALS

FIGURE 37 COOK MEDICAL: SEGMENTAL REVENUE

FIGURE 38 COOK MEDICAL: REGIONAL REVENUE

FIGURE 39 VASCULAR CONCEPTS: KEY FINANCIALS

FIGURE 40 VASCULAR CONCEPTS: SEGMENTAL REVENUE

FIGURE 41 VASCULAR CONCEPTS: REGIONAL REVENUE

FIGURE 42 STENTYS S.A.: KEY FINANCIALS

FIGURE 43 STENTYS S.A.: SEGMENTAL REVENUE

FIGURE 44 STENTYS S.A.: REGIONAL REVENUE

FIGURE 45 C. R. BARD: KEY FINANCIALS

FIGURE 46 C. R. BARD: SEGMENTAL REVENUE

FIGURE 47 C. R. BARD: REGIONAL REVENUE

FIGURE 48 MERIL LIFE SCIENCES: KEY FINANCIALS

FIGURE 49 MERIL LIFE SCIENCES: SEGMENTAL REVENUE

FIGURE 50 MERIL LIFE SCIENCES: REGIONAL REVENUE

FIGURE 51 CORDIS CORPORATION: KEY FINANCIALS

FIGURE 52 CORDIS CORPORATION: SEGMENTAL REVENUE

FIGURE 53 CORDIS CORPORATION: REGIONAL REVENUE

FIGURE 54 W. L. GORE & ASSOCIATES: KEY FINANCIALS

FIGURE 55 W. L. GORE & ASSOCIATES: SEGMENTAL REVENUE

FIGURE 56 W. L. GORE & ASSOCIATES: REGIONAL REVENUE